Research ArticleResearch Article

Inhibition of the Growth of Raji Cells by Precursor MicroRNA-15a

Dong-mei HE and Qin CHEN
Clinical Oncology and Cancer Research February 2010, 7 (1) 22-26; DOI: https://doi.org/10.1007/s11805-010-0022-1

References

  1. ↵
    1. Calin GA,
    2. Croce CM.
    MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
    OpenUrlCrossRefPubMedWeb of Science
    1. Li N,
    2. Flynt AS,
    3. Kim HR, et al.
    Dispatched Homolog 2 is targeted by miR-214 through a combination of three weak microRNA recognitionsites. Nucleic Acids Res. 2008; 36: 4277-4285.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Nahvi A,
    2. Shoemaker CJ,
    3. Green R.
    An expanded seed sequence definition accounts for full regulation of the hid 3’ UTR by bantam miRNA. RNA 2009; 15: 814-822.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Lewis BP,
    2. Burge CB,
    3. Bartel DP.
    Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
    OpenUrlCrossRefPubMedWeb of Science
    1. Steitz JA,
    2. Vasudevan S.
    miRNPs: versatile regulators of gene expression in vertebrate cells. Biochem Soc Trans 2009; 37: 931-935.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Wakiyama M,
    2. Takimoto K,
    3. Ohara O, et al.
    Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system. Genes Dev 2007; 21: 1857-1862.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Calin GA,
    2. Dumitru CD,
    3. Shimizu M, et al.
    Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529.
    OpenUrlAbstract/FREE Full Text
    1. Ouillette P,
    2. Erba H,
    3. Kujawski L, et al.
    Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 2008; 68: 1012-1021.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Calin GA,
    2. Croce CM.
    Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Semin Oncol 2006; 33: 167-173.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Amelia C,
    2. George AC,
    3. Muller F, et al.
    miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944-13949.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Calin GA,
    2. Cimmino A,
    3. Fabbri M, et al.
    MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008; 105: 5166-5171.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Calin GA,
    2. Ferracin M,
    3. Cimmino A, et al.
    A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-1801.
    OpenUrlCrossRefPubMedWeb of Science
    1. Zhang B,
    2. Pan X,
    3. Cobb GP, et al.
    microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12.
    OpenUrlCrossRefPubMedWeb of Science
    1. Jay C,
    2. Nemunaitis J,
    3. Chen P, et al.
    miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol 2007; 26: 293-300.
    OpenUrlCrossRefPubMedWeb of Science
    1. Osada H,
    2. Takahashi T.
    MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 2007; 28: 2-12.
    OpenUrlCrossRefPubMedWeb of Science
    1. Garzon R,
    2. Volinia S,
    3. Liu CG, et al.
    MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008; 111: 3183-3189.
    OpenUrlAbstract/FREE Full Text
    1. Singh P,
    2. Alley TL,
    3. Wright SM, et al.
    Global changes in processing of mRNA 3’ untranslated regions characterize clinically distinct cancer subtypes. Cancer Res 2009; 69: 9422-9430.
    OpenUrlAbstract/FREE Full Text
    1. Pedersen IM,
    2. Otero D,
    3. Kao E, et al.
    Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med 2009; 1: 288-95.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Bryant A,
    2. Lutherborrow M,
    3. Ma D.
    The clinicopathological relevance of microRNA in normal and malignant haematopoiesis. Pathology 2009; 41: 204-213.
    OpenUrl
  20. ↵
    1. Ji Q,
    2. Hao X,
    3. Meng Y, et al.
    Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008; 8: 266.
    OpenUrlCrossRefPubMed
    1. Silber J,
    2. Lim DA,
    3. Petritsch C, et al.
    miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008; 6: 14.
    OpenUrlCrossRefPubMed
    1. Long XB,
    2. Sun GB,
    3. Hu S, et al.
    Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncol Rep 2009; 22: 1189-1195.
    OpenUrlPubMedWeb of Science
    1. McLaughlin J,
    2. Cheng D,
    3. Singer O, et al.
    Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics. Proc Natl Acad Sci USA 2007; 104: 20501-20506.
    OpenUrlAbstract/FREE Full Text
    1. Zhou L,
    2. Qi X,
    3. Potashkin JA, et al.
    MicroRNAs miR-186 and miR-150 down-regulate expression of the proapoptotic purinergic P2X7 receptor by activation of instability sites at the 3’-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 2008; 283: 28274-28286.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Cole KA,
    2. Attiyeh EF,
    3. Mosse YP, et al.
    A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 2008; 6: 735-742.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords